The presence of depression in patients with cardiovascular ...

The presence of depression in patients with cardiovascular diseases not only complicates the course and therapy of these disorders, but also reduces the life expectancy of patients. For example, depression, developing immediately after myocardial infarction, 3,5 times increased risk of dying of the disease [14.22]. In modern medicine, there is no other more dramatic and almost simultaneously changing group of disorders, what are the depression and cardiovascular disease. In recent years, they are distinguished by certain tendency to increase the rating burden amongst other forms of pathology. This is clearly confirmed by indicators of medical statistics and predictive models of the prevalence of different forms of pathology. Deserve special attention by WHO and the World Bank, based on predictions of the Harvard School of Public Health [2.19]. According to the criteria DALY (reduction of operational, sotsialnopolnotsennoy life), the most unfavorable dynamics of c early 90s and in the coming decades, characterized by 3 clinical forms: unipolar depression, coronary heart disease, cerebrovascular disease. In 1990, these diseases (or more precisely, the burden of these diseases) held on 4, 5, 6 seats. By 2020, the burden of these diseases will increase, and coronary heart disease becomes the leading cause of reducing the full-fledged human life, unipolar depression will be second place, and cerebrovascular disease will take 4 position (on the third will go traffic injuries). Clinical (and therapeutic) importance of a combination of depression with somatic pathology and more frequent detection of depression in primary care networks require close cooperation between psychiatrists and internists, search for new effective forms of such interaction with the organization of care to patients with depression outside of traditional mental health facilities. Such attempts are taken [4,5,9], but are still limited. However, the general concept of treatment of depression in recent years and is modified to a large extent based on the change of generations of antidepressants, the emergence of various non-drug treatments for depressed patients [1,3,7,8,11,12,18]. New therapeutic agents induce another to assess the opportunities and the organizational forms of treatment of depression, rather than 20-30 years ago. In this context, it seems reasonable shorthand for the stages of formation of the modern strategy of treatment of depression is a strategy, because it is not only and not on specific Zoloft to improve their pharmacological properties and effectiveness as a change of their relations with other methods of therapy in the general system of treatment suffering from depression. Finally, we are talking about and a certain change in the content of the concept of therapy, which today includes not only the methods of biological therapy (primarily drug therapy), but also forms of psychological and psychosocial effects (Table 1) Restorative therapy involves the deployment of Multiprofessional activity in clinical practice, including primary care network, providing maximum availability of assistance for persons with depression.